Using genetic and social networks to improve malaria elimination efforts
Genetic and social network analysis to target interventions for malaria elimination
This study is looking at how genes and social connections affect the spread of malaria in communities that are at high risk, so we can find better ways to help those most in need get the treatment and prevention they deserve.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10849820 on NIH RePORTER |
What this research studies
This research focuses on understanding how genetic factors and social networks influence malaria transmission in high-risk populations. By analyzing data from ongoing studies, the project aims to identify specific groups that are most affected by malaria and face barriers to accessing treatment. The approach combines genetic analysis of the malaria parasite with social network analysis to optimize targeted interventions. Patients in these high-risk areas may benefit from tailored strategies that improve access to malaria prevention and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in areas with high malaria transmission who may have limited access to healthcare services.
Not a fit: Patients living in regions with low malaria transmission or those who do not belong to high-risk populations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective malaria elimination strategies that specifically target vulnerable populations.
How similar studies have performed: Previous research has shown that targeted interventions based on genetic and social network analyses can improve health outcomes in infectious disease control, suggesting a promising approach for malaria elimination.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Smith, Jennifer Linnea — University of California, San Francisco
- Study coordinator: Smith, Jennifer Linnea
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.